NAMSW
NewAmsterdam Pharma Company N.V.
NASDAQ · Healthcare · Biotechnology · NL
$13.88
−3.88%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-29.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jan 29, 2026 | Kooij Louise Frederika · officer: Chief Accounting Officer | M-Exempt | 39,816 | $11 |
| Jan 29, 2026 | Kooij Louise Frederika · officer: Chief Accounting Officer | M-Exempt | 32,612 | $11 |
| Jan 29, 2026 | Kooij Louise Frederika · officer: Chief Accounting Officer | Sale | 32,612 | $32 |
| Jan 29, 2026 | Kooij Louise Frederika · officer: Chief Accounting Officer | Sale | 39,816 | $33 |
| Jan 27, 2026 | Kooij Louise Frederika · officer: Chief Accounting Officer | M-Exempt | 38,172 | $11 |
| Jan 27, 2026 | Kooij Louise Frederika · officer: Chief Accounting Officer | M-Exempt | 34,400 | $11 |
| Jan 27, 2026 | Kooij Louise Frederika · officer: Chief Accounting Officer | Sale | 25,405 | $33 |
| Jan 27, 2026 | Kooij Louise Frederika · officer: Chief Accounting Officer | Sale | 34,091 | $33 |
| Jan 27, 2026 | Kooij Louise Frederika · officer: Chief Accounting Officer | Sale | 12,767 | $34 |
| Jan 27, 2026 | Kooij Louise Frederika · officer: Chief Accounting Officer | Sale | 309 | $33 |
| Jan 22, 2026 | Somaiya Mayur Ian · officer: Chief Financial Officer | M-Exempt | 60,216 | $9.26 |
| Jan 22, 2026 | Somaiya Mayur Ian · officer: Chief Financial Officer | M-Exempt | 39,784 | $9.26 |
| Jan 22, 2026 | Somaiya Mayur Ian · officer: Chief Financial Officer | Sale | 900 | $31 |
| Jan 22, 2026 | Somaiya Mayur Ian · officer: Chief Financial Officer | Sale | 15,422 | $33 |
| Jan 22, 2026 | Somaiya Mayur Ian · officer: Chief Financial Officer | Sale | 39,712 | $32 |
| Jan 22, 2026 | Somaiya Mayur Ian · officer: Chief Financial Officer | Sale | 24,362 | $34 |
| Jan 22, 2026 | Somaiya Mayur Ian · officer: Chief Financial Officer | Sale | 19,604 | $32 |
| Jan 9, 2026 | van der Kamp Hilde Johanna · director | A-Award | 15,300 | $35 |
| Jan 9, 2026 | van der Kamp Hilde Johanna · director | A-Award | 3,400 | $0.00 |
| Jan 9, 2026 | Gulfo Adele M. · director | A-Award | 15,300 | $35 |
| Jan 9, 2026 | Gulfo Adele M. · director | A-Award | 3,400 | $0.00 |
| Jan 9, 2026 | Davidson Michael H. · director, officer: Chief Executive Officer | A-Award | 81,000 | $0.00 |
| Jan 9, 2026 | Davidson Michael H. · director, officer: Chief Executive Officer | Sale | 11,582 | $0.00 |
| Jan 9, 2026 | Davidson Michael H. · director, officer: Chief Executive Officer | A-Award | 364,000 | $35 |
| Jan 9, 2026 | Lewis William · director | A-Award | 15,300 | $35 |
| Jan 9, 2026 | Lewis William · director | A-Award | 3,400 | $0.00 |
| Jan 9, 2026 | Smither John W · director | A-Award | 15,300 | $35 |
| Jan 9, 2026 | Smither John W · director | A-Award | 3,400 | $0.00 |
| Jan 9, 2026 | McKenna Mark C. · director | A-Award | 15,300 | $35 |
| Jan 9, 2026 | McKenna Mark C. · director | A-Award | 3,400 | $0.00 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jan 29, 2026